PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
57 hedge funds and large institutions have $106M invested in PLx Pharma Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 16 closing their positions.
105% more call options, than puts
Call options by funds: $3.33M | Put options by funds: $1.62M
92% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 12
10% less funds holding
Funds holding: 63 → 57 (-6)
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
42% less capital invested
Capital invested by funds: $184M → $106M (-$77.4M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
MSD Partners
New York
|
+$44M |
| 2 |
Morgan Stanley
New York
|
+$7.58M |
| 3 |
Millennium Management
New York
|
+$1.68M |
| 4 |
BlackRock
New York
|
+$1.43M |
| 5 |
Two Sigma Investments
New York
|
+$1.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$7.18M |
| 2 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$4.05M |
| 3 |
MS
Maven Securities
St Helier,
Jersey
|
-$3.87M |
| 4 |
Jane Street
New York
|
-$1.62M |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$1.53M |
PLXP Hedge Fund Activity: Q4 2021 in Review
57 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q4 2021, worth a combined $106M — down 42% from $184M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of PLXP and 12 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 23 added.
The largest buyer was MSD Partners, adding an estimated $44M. The largest seller was EAM Investors, exiting entirely with an estimated $7.18M sold.
- 57 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q4 2021, down from 63 in Q3 2021.
- Funds reported $106M of PLx Pharma Inc. Common Stock stock for Q4 2021, down 42% quarter-over-quarter.
- 12 funds opened new PLx Pharma Inc. Common Stock positions in Q4 2021 and 16 closed out, a net change of -4 holders.
- The largest PLx Pharma Inc. Common Stock buyer in Q4 2021 was MSD Partners, an estimated $44M added.
- The largest PLx Pharma Inc. Common Stock seller in Q4 2021 was EAM Investors, an estimated $7.18M sold.
Based on aggregated 13F filings for Q4 2021.